MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status. MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker. We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for guiding clinical decision-making." title="" class="btn" data-container="body" data-html="true" data-id="177961" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="MSInsight"> 2,148
Activities
Technologies
Entity types
Location
Paris, France
Paris
France
Employees
Scale: 2-10
Estimated: 8
SIREN
910844729Engaged corporates
39Added in Motherbase
2 years, 2 months agoUnlocking the Power of Genomics: Advancing Cancer Care and Precision Medicine
MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status.
MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker.
We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for guiding clinical decision-making.
Microsatellite Instability, Next-Generation Sequencing, Diagnostic Test, Bioinformatics, Oncology, Precision Medicine, Hereditary Cancer, and Defective Mismatch Repair
Unlocking the Power of Genomics: Advancing Cancer Care and Precision Medicine
MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status.
MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker.
We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for guiding clinical decision-making.
Empowering precision oncology by unlocking insights on MSI via Next-Generation Sequencing for better tumor biomarker diagnosis and improved patient care.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() BFM Business Media, Broadcast Media Production and Distribution | BFM Business Media, Broadcast Media Production and Distribution | Other 25 Mar 2025 | | |
![]() Avolta Finance, Investment Banking | Avolta Finance, Investment Banking | Other 14 Mar 2025 | | |
![]() Hello Tomorrow Trade show, Business Consulting and Services | Hello Tomorrow Trade show, Business Consulting and Services | Other 14 Nov 2024 | | |
![]() Maddyness Media, Media Production | Maddyness Media, Media Production | Other 21 Jun 2024 | | |
![]() Illumina Biotechnology, Biotechnology Research | Illumina Biotechnology, Biotechnology Research | Other 21 Aug 2024 | | |
![]() Viva Technology Trade show, IT Services and IT Consulting | Viva Technology Trade show, IT Services and IT Consulting | Other 26 May 2024 | | |
![]() Publicis Groupe Advertising, Advertising Services | Publicis Groupe Advertising, Advertising Services | Other 26 May 2024 | | |
![]() Ministry of Economy Government Administration | Ministry of Economy Government Administration | Other 13 Mar 2024 | | |
![]() France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 3 Dec 2024 | | |
![]() ASSOCIATION FRANCAISE DES POLES DE COMPETITIVITE French Cluster | ASSOCIATION FRANCAISE DES POLES DE COMPETITIVITE French Cluster | Other 23 Apr 2024 | |